Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances M Palmieri

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The Oncologist|October 9, 2010
Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 statusSurabhi Amar, Ann E McCullough, Winston Tan, et al.
Breast Cancer Research and Treatment|March 13, 2013
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerAlvaro Moreno-Aspitia, Amylou C Dueck, Ismael Ghanem-Cañete, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The Oncologist|October 9, 2010
Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 statusSurabhi Amar, Ann E McCullough, Winston Tan, et al.
Breast Cancer Research and Treatment|March 13, 2013
RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerAlvaro Moreno-Aspitia, Amylou C Dueck, Ismael Ghanem-Cañete, et al.
Pageof 2